91 results on '"Rabelink T"'
Search Results
2. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy
3. POS0185 BELIMUMAB DISRUPTS MEMORY B-CELL TRAFFICKING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
4. MO251HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS PATIENTS*
5. 4 Hypertensie
6. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool
7. Endothelin and Renal Function: From Theory to Therapy
8. Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains
9. FRI0329 The net-effect of combining rituximab with belimumab in severe systemic lupus erythematosus
10. Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis
11. Abdominal aortic calcification on a plain X-ray and the relation with significant coronary artery disease in asymptomatic chronic dialysis patients
12. Bone material strength index as measured by impact microindentation is altered in patients with acromegaly
13. P22 A NOVEL METHOD FOR HIGH-THROUGHPUT DETECTION AND QUANTIFICATION OF NEUTROPHIL EXTRACELLULAR TRAPS REVEALS ROS-INDEPENDENT NET RELEASE WITH IMMUNE COMPLEXES
14. P28 TAC-TIC USE OF TACROLIMUS-BASED REGIMENS IN LUPUS NEPHRITIS
15. SAT0025 Enhanced Capacity of MPO-ANCA Compared To PR3-ANCA for Inducing Neutrophil Extracellular Traps
16. AB0425 Tac-Tic Use of Tacrolimus-Based Regimens in Lupus Nephritis
17. High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD
18. Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
19. Belimumab after rituximab as maintenance therapy in lupus nephritis
20. Circulating MicroRNAs Associate With Pathogenesis of Diabetic Nephropathy and Normalize After Simultaneous Pancreas-Kidney Transplantation.
21. Telomere shortening: a diagnostic tool and therapeutic target for cardiovascular disease?
22. DIALYSIS VASCULAR ACCESS
23. DIALYSIS CARDIOVASCULAR COMPLICATIONS 1
24. TRANSPLANTATION BASIC SCIENCE, ALLOGENIC AND XENOGENIC TOLERANCE
25. DIALYSIS CARDIOVASCULAR COMPLICATIONS
26. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients
27. Echocardiographical determinants of an abnormal spatial QRS-T angle in chronic dialysis patients
28. Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
29. Arteriovenous access failure: more than just intimal hyperplasia?
30. A possible role of cystatin C in adipose tissue homeostasis may impact kidney function estimation in metabolic syndrome
31. MicroRNA-155 Functions as a Negative Regulator of RhoA Signaling in TGF-β-induced Endothelial to Mesenchymal Transition
32. L’insuffisance rénale chronique est associée à des anomalies de la niche hématopoïétique chez la souris
33. Antenatal excessive sodium intake induces adverse vascular remodelling in offspring
34. MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation
35. Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease
36. PREVENTION OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION
37. TRENDS IN ALBUMINURIA UNDER RAS SUPPRESSION AND RELATIONSHIP WITH CARDIOVASCULAR DISEASE
38. PREVENTION OF MICROALBUMINURIA: EFFECT OF BASELINE UACR AND CHANGES IN THE EGFR ON OUTCOME (ROADMAP TRIAL)
39. A case of mononucleosis infectiosa presenting with cholemic nephrosis
40. Islet transplantation in type 1 diabetes
41. Adipose tissue-derived stem cells: can impure cell preparations give pure results?
42. Circulating cells and dialysis: improving cell number or increasing session number?
43. Inflammation, vascular injury and repair in rheumatoid arthritis
44. Urinary properdin excretion is associated with intrarenal complement activation and poor renal function
45. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation
46. Salt is getting under our skin
47. The current status of interventions aiming at reducing sudden cardiac death in dialysis patients
48. Bevacizumab-related hypertension: Search for underlying mechanisms
49. Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians
50. Optimal predialysis care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.